Angélica Julián Castrejón, Rosa Marene Hernández Martínez, Diana Rivero Méndez, Israel Nayensei Gil Velázquez, Juan Heriberto Rodríguez Piña, Juan Manuel Salgado Camacho, Nicolás Teyes Calva, Sayuri I. Espíndola Chavarría, Patricia A. Meza-Meneses, and Carlos Alberto Castro-Fuentes
Surgical intervention is a key element in the management of patients diagnosed with mucormycosis. A retrospective cohort study was carried out, in which patients with a proven diagnosis of mucormycosis were evaluated over a period of 10 years, according to the MSGERC criteria. A descriptive analysis of the clinical characteristics, comorbidities, imaging, and microbiology studies, as well as medical and surgical treatment and the type of prosthesis was carried out. A total of 22 cases were identified, of which 54.5% (n = 12) of the population were men. Furthermore, 77.2% (n = 17) of the population had diabetes mellitus. The main antifungal treatment implemented was liposomal amphotericin B (77.2%, n = 17). The most affected structures in our patients were the paranasal sinuses (n = 18; 81%), followed by the maxilla and orbit (n = 15; 68%), nose (n = 12; 54%), central nervous system (n = 11; 50%), and skin and soft tissues (n = 2;